Trial
NCT00377455
Placebo Controlled Trial of Bosentan in Scleroderma Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Actelion
Condition
Systemic Scleroderma
Intervention
Bosentan
Why stopped
Study was terminated due to inadequate enrolment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-24